rs61752479

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000036.3(AMPD1):​c.143C>T​(p.Pro48Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.112 in 1,613,946 control chromosomes in the GnomAD database, including 11,561 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity,other (no stars).

Frequency

Genomes: 𝑓 0.086 ( 781 hom., cov: 32)
Exomes 𝑓: 0.11 ( 10780 hom. )

Consequence

AMPD1
NM_000036.3 missense

Scores

6
7
5

Clinical Significance

Conflicting classifications of pathogenicity; other criteria provided, conflicting classifications U:2B:5O:1

Conservation

PhyloP100: 9.35
Variant links:
Genes affected
AMPD1 (HGNC:468): (adenosine monophosphate deaminase 1) Adenosine monophosphate deaminase 1 catalyzes the deamination of AMP to IMP in skeletal muscle and plays an important role in the purine nucleotide cycle. Two other genes have been identified, AMPD2 and AMPD3, for the liver- and erythocyte-specific isoforms, respectively. Deficiency of the muscle-specific enzyme is apparently a common cause of exercise-induced myopathy and probably the most common cause of metabolic myopathy in the human. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030060112).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.132 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
AMPD1NM_000036.3 linkuse as main transcriptc.143C>T p.Pro48Leu missense_variant 3/16 ENST00000520113.7 NP_000027.3
AMPD1NM_001172626.2 linkuse as main transcriptc.131C>T p.Pro44Leu missense_variant 2/15 NP_001166097.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
AMPD1ENST00000520113.7 linkuse as main transcriptc.143C>T p.Pro48Leu missense_variant 3/161 NM_000036.3 ENSP00000430075 P4P23109-1
AMPD1ENST00000369538.4 linkuse as main transcriptc.131C>T p.Pro44Leu missense_variant 2/152 ENSP00000358551 A1P23109-2
AMPD1ENST00000637080.1 linkuse as main transcriptc.146C>T p.Pro49Leu missense_variant, NMD_transcript_variant 2/145 ENSP00000489753

Frequencies

GnomAD3 genomes
AF:
0.0865
AC:
13148
AN:
152026
Hom.:
781
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0221
Gnomad AMI
AF:
0.135
Gnomad AMR
AF:
0.0727
Gnomad ASJ
AF:
0.0735
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.0282
Gnomad FIN
AF:
0.119
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.134
Gnomad OTH
AF:
0.0839
GnomAD3 exomes
AF:
0.0876
AC:
22018
AN:
251420
Hom.:
1331
AF XY:
0.0888
AC XY:
12065
AN XY:
135876
show subpopulations
Gnomad AFR exome
AF:
0.0202
Gnomad AMR exome
AF:
0.0509
Gnomad ASJ exome
AF:
0.0768
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.0355
Gnomad FIN exome
AF:
0.116
Gnomad NFE exome
AF:
0.132
Gnomad OTH exome
AF:
0.0932
GnomAD4 exome
AF:
0.115
AC:
167963
AN:
1461802
Hom.:
10780
Cov.:
32
AF XY:
0.113
AC XY:
82083
AN XY:
727200
show subpopulations
Gnomad4 AFR exome
AF:
0.0179
Gnomad4 AMR exome
AF:
0.0524
Gnomad4 ASJ exome
AF:
0.0794
Gnomad4 EAS exome
AF:
0.000151
Gnomad4 SAS exome
AF:
0.0357
Gnomad4 FIN exome
AF:
0.119
Gnomad4 NFE exome
AF:
0.132
Gnomad4 OTH exome
AF:
0.103
GnomAD4 genome
AF:
0.0864
AC:
13146
AN:
152144
Hom.:
781
Cov.:
32
AF XY:
0.0837
AC XY:
6223
AN XY:
74378
show subpopulations
Gnomad4 AFR
AF:
0.0220
Gnomad4 AMR
AF:
0.0726
Gnomad4 ASJ
AF:
0.0735
Gnomad4 EAS
AF:
0.000578
Gnomad4 SAS
AF:
0.0278
Gnomad4 FIN
AF:
0.119
Gnomad4 NFE
AF:
0.134
Gnomad4 OTH
AF:
0.0825
Alfa
AF:
0.116
Hom.:
1867
Bravo
AF:
0.0799
TwinsUK
AF:
0.144
AC:
533
ALSPAC
AF:
0.127
AC:
491
ESP6500AA
AF:
0.0234
AC:
103
ESP6500EA
AF:
0.133
AC:
1144
ExAC
AF:
0.0884
AC:
10728
Asia WGS
AF:
0.0220
AC:
77
AN:
3478
EpiCase
AF:
0.125
EpiControl
AF:
0.128

ClinVar

Significance: Conflicting classifications of pathogenicity; other
Submissions summary: Uncertain:2Benign:5Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2Other:1
other, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 07, 2018- Variant classified as "other reportable" ??? variant is clinically benign (not associated with disease) but is reported when observed (e.g. pseudodeficiency alleles).
Benign, criteria provided, single submitterclinical testingGeneDxJun 09, 2021This variant is associated with the following publications: (PMID: 1631143, 33250842, 21228398, 20981092) -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2018- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Muscle AMP deaminase deficiency Uncertain:1Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Uncertain significance, no assertion criteria providedclinical testingClinical Genomics Laboratory, Stanford MedicineJan 06, 2021The p.Pro81Leu variant in the AMPD1 gene has been previously reported in 11 unrelated individuals with reported AMPD deficiency (Morisaki et al., 1992). Of note, all individuals were homozygous for this variant as well as the p.Gln45* variant. The highest allele frequency of the p.Pro81Leu variant was identified in the European population at 17,214/129,128 chromosomes (13.33%) by the Genome Aggregation Database (http://gnomad.broadinstitute.org/). Computational tools predict that the p.Pro81Leu variant is deleterious; however, the accuracy of in silico algorithms is limited. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, the significance of the p.Pro81Leu variant is uncertain. Additional information is needed to resolve the significance of this variant. [ACMG evidence codes used: PP3] -
Benign, criteria provided, single submitterclinical testingAl Jalila Children’s Genomics Center, Al Jalila Childrens Speciality HospitalJan 06, 2020- -
AMPD1-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesDec 01, 2023This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.63
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Uncertain
0.030
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.67
D;.
Eigen
Pathogenic
0.71
Eigen_PC
Pathogenic
0.69
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.83
T;T
MetaRNN
Benign
0.0030
T;T
MetaSVM
Benign
-0.43
T
MutationAssessor
Uncertain
2.4
M;.
MutationTaster
Benign
5.7e-12
P;P;P
PrimateAI
Uncertain
0.58
T
PROVEAN
Pathogenic
-4.8
D;D
REVEL
Uncertain
0.51
Sift
Pathogenic
0.0
D;D
Sift4G
Uncertain
0.012
D;D
Vest4
0.32
MPC
0.46
ClinPred
0.028
T
GERP RS
5.6
Varity_R
0.66
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61752479; hg19: chr1-115231254; COSMIC: COSV62415390; COSMIC: COSV62415390; API